Electrothermal Arthroscopic Capsulorrhaphy (ETAC) and Open Inferior Capsular Shift in Patients With Shoulder Instability
Arthroscopic Electrothermal Capsulorrhaphy, ETAC, Versus Open Inferior Capsular Shift, ICS in Patients With Shoulder Instability: A Multicentre Randomized Clinical Trial
3 other identifiers
interventional
58
1 country
7
Brief Summary
This trial will compare the effectiveness of electrothermal arthroscopic capsulorrhaphy (ETAC) to the current reference standard procedure, open inferior capsular shift (ICS), for the treatment of shoulder instability caused by ligamentous capsular redundancy. Multi-directional instability (MDI) and multi-directional laxity with anteroinferior instability (MDL-AII) are the two types of shoulder instabilities included in this trial. Hypothesis: There is no difference in disease-specific quality of life between patients undergoing an ETAC versus an open ICS for the treatment of shoulder instability caused by capsular ligamentous redundancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 1999
Longer than P75 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 1999
CompletedFirst Submitted
Initial submission to the registry
November 7, 2005
CompletedFirst Posted
Study publicly available on registry
November 9, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedJuly 13, 2015
July 1, 2015
10.2 years
November 7, 2005
July 9, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Western Ontario Shoulder Instability (WOSI) Index
Baseline, 3, 6, 12, 24 months post-operatively
Secondary Outcomes (5)
Constant score (European Shoulder Society)
Baseline, 3, 6, 12, 24 months post-operatively
Recurrent instability
Up to 24 months post-operatively
Complications
Intra-operatively and up to 8 weeks post-operatively
Operative time
Day of surgery
American Shoulder and Elbow Surgeon's Score (ASES)
Baseline, 3, 6, 12, 24 months post-operatively
Study Arms (2)
ETAC
ACTIVE COMPARATOROpen ICS
ACTIVE COMPARATORInterventions
The Oratec Vulcan Generator electro-thermal system (Oratec Interventions Inc., Menlo Park, CA, USA) delivers heat at 75C and 40 watts. An anterior portal is established above the superior border of the subscapularis tendon. For MDI patients, the heat probe is introduced through the posterior portal. The capsule is shrunk using a grid pattern until excess volume is diminished. The extent of the heat probe application is identical to the landmarks used for the open ICS. Care is taken to avoid applying heat to the capsule in the region from 5-7 o'clock within 1cm of the glenoid rim to avoid the axillary nerve. The method of heat application utilizes a grid pattern, which is less likely to cause dissolution of the capsule and subsequent catastrophic capsular loss.
MDI: lateral capsule released antero-superiorly from rotator interval to equator, posteriorly on the humeral neck. MDL-AII: release from the rotator interval to 7 o'clock (Right) or 5 o'clock (Left) position on humeral neck, to tighten the 2 bands of the inferior GH ligaments, middle GH ligament and rotator interval. Bone adjacent to the articular surface on the surgical neck of the humerus is roughened to create a bleeding bony bed. With the arm in 0deg flexion, 30deg abduction, 30deg external rotation, the inferior leaflet of the capsule is shifted superiorly and slightly laterally, and sutured to the rim of the capsule using a non-absorbable suture. Superior leaflet is shifted inferiorly and sutured. Subscapularis is repaired at its anatomic length using interrupted sutures.
Eligibility Criteria
You may qualify if:
- Ages 14 years or greater
- Diagnosis of MDI or MDL-AII. Diagnosis will require two or more of the following:
- Symptomatic translation (pain or discomfort) in one or more directions: anterior, inferior and/or posterior;
- Ability to elicit unwanted glenohumeral translations that reliably produce symptoms with one of the following tests: the anterior and posterior apprehension tests, the anterior and posterior load and shift tests, the fulcrum test, the relocation test, the Fukuda test, and/or the push-pull or stress test with the patient supine;
- Presence of a positive sulcus sign of 1 centimetre or greater gap that reproduces the patient's clinical symptoms of instability and should be both palpable and visible;
- Symptoms of instability: subluxation or dislocation.
- Written informed consent
- Failed at least 6 months of non-operative treatment
- Confirmed capsular-ligamentous redundancy as determined by diagnostic arthroscopy examination.
You may not qualify if:
- Neurologic disorder (ie: axillary nerve injury; syringomyelia)
- Cases involving third party compensation
- Patients with primary posterior instability
- A bony abnormality (Hill Sachs/bony Bankart) on standard series of x-rays consisting of a minimum of an anteroposterior view, lateral in the scapular plane and an axillary view
- Presence of a Bankart lesion on arthroscopic exam of the joint
- Presence of an unstable biceps anchor (ie: superior labral anterior and posterior \[SLAP\] lesion) on arthroscopic exam of the joint
- Presence of a full-thickness rotator cuff tear.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- Canadian Institutes of Health Research (CIHR)collaborator
- The Arthritis Society, Canadacollaborator
- Smith and Nephew (formerly Oratec Interventions)collaborator
Study Sites (7)
University of Calgary Sport Medicine Centre
Calgary, Alberta, T2N 1N4, Canada
Grey Nuns Community Hospital
Edmonton, Alberta, T6L 5X8, Canada
Royal Columbian Hospital
New Westminster, British Columbia, V3L 3W7, Canada
Pan Am Medical and Surgical Centre
Winnipeg, Manitoba, R3M 3E4, Canada
Hamilton General Hospital
Hamilton, Ontario, L8L 5G8, Canada
Fowler Kennedy Sport Medicine Centre
London, Ontario, N6A 3K7, Canada
St. Joseph's Health Centre
London, Ontario, N6A 4L6, Canada
Related Publications (2)
Mohtadi NG, Hollinshead RM, Ceponis PJ, Chan DS, Fick GH. A multi-centre randomized controlled trial comparing electrothermal arthroscopic capsulorrhaphy versus open inferior capsular shift for patients with shoulder instability: protocol implementation and interim performance: lessons learned from conducting a multi-centre RCT [ISRCTN68224911; NCT00251160]. Trials. 2006 Feb 2;7:4. doi: 10.1186/1745-6215-7-4.
PMID: 16542033BACKGROUNDMohtadi NG, Kirkley A, Hollinshead RM, McCormack R, MacDonald PB, Chan DS, Sasyniuk TM, Fick GH, Paolucci EO; Joint Orthopaedic Initiative for National Trials of the Shoulder-Canada. Electrothermal arthroscopic capsulorrhaphy: old technology, new evidence. A multicenter randomized clinical trial. J Shoulder Elbow Surg. 2014 Aug;23(8):1171-80. doi: 10.1016/j.jse.2014.02.022. Epub 2014 Jun 15.
PMID: 24939380RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicholas Mohtadi, MD, FRCSC
University of Calgary Sport Medicine Centre
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
November 7, 2005
First Posted
November 9, 2005
Study Start
December 1, 1999
Primary Completion
February 1, 2010
Study Completion
February 1, 2010
Last Updated
July 13, 2015
Record last verified: 2015-07